Taste, pain, or response to stress—nearly all essential functions in the human body are regulated by molecular switches ...

Experts are sounding the alarm about increased use of kratom and about highly concentrated products containing 7-OH, a more ...

In England, 5.5 million people have high blood pressure without knowing - bad sleep, medications, contraception and stress ...

DelveInsight's 'IGALMI Market Size, Forecast, and Market Insight Report' highlights the details around IGALMI, a sublingual film formulation of the approved alpha2-adrenergic receptor agonist ...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) informed ...

Discover the Best Kratom Strains and Products for Natural Energy, Focus, and Motivation - Featuring Super Speciosa's Clean, ...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) informed ...

The FDA has accepted the new drug application for the antipsychotic Bysanti and set a goal date for February 21, 2026.

Net Loss: BioXcel Therapeutics had a net loss of $7.3 million for the first quarter of 2025, compared to a net loss of $26.8 ...

Considering the bioequivalence study of Brexpiprazole Tablets 0.25mg /0.5 mg/1mg/2mg/3mg/4mg, the Subject Expert Committee ...

Vanda Pharma announces Bysanti NDA with US filing; US FDA decision expected in early 2026: Washington Tuesday, May 6, 2025, 18:00 Hrs [IST] Vanda Pharmaceuticals Inc. (Vanda) anno ...